Connect with us

Health

Critical Medicines Act negotiations begin, with urgency stressed by co-legislators

SHARE:

Published

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

The kick-off trilogue on the Critical Medicines Act (CMA) took place on Monday evening (2 February), with discussions described as constructive. Co-legislators reiterated both their readiness to move forward and the urgency of the file, given ongoing concerns around the EU’s security of medicine supply.

Earlier that afternoon, addressing the European Parliament’s Public Health Committee, Cypriot Health Minister Neophytos Charalambides said the CMA was a key priority of the Cypriot presidency. He expressed hope that a political agreement could be reached within the next six months.

“This is a top priority for us in the current geopolitical context, where the availability of medicines can be challenged. Strengthening our capacity to provide critical medicines is key. We must ensure that every citizen has reliable access to the medicines they need,” Charalambides said.

The trilogue comes as European Commission Vice President and Industry Commissioner Stéphane Séjourné called for the EU to adopt a “European preference”...

Share this article:

Share this:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.

Trending